These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15975420)

  • 1. Apolipoprotein E polymorphism and the risk of acute nephropathy after cardiac surgery.
    Liberopoulos EN; Tsouli S; Elisaf MS
    Ann Thorac Surg; 2005 Jul; 80(1):382-3; author reply 383. PubMed ID: 15975420
    [No Abstract]   [Full Text] [Related]  

  • 2. Apolipoprotein E4 increases aortic atheroma burden in cardiac surgical patients.
    Ti LK; Mackensen GB; Grocott HP; Laskowitz DT; Phillips-Bute BG; Milano CA; Hilton AK; Newman MF; Mathew JP;
    J Thorac Cardiovasc Surg; 2003 Jan; 125(1):211-3. PubMed ID: 12539012
    [No Abstract]   [Full Text] [Related]  

  • 3. The genetic determinants of renal impairment following cardiac surgery.
    Yates RB; Stafford-Smith M
    Semin Cardiothorac Vasc Anesth; 2006 Dec; 10(4):314-26. PubMed ID: 17200089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic polymorphism of the E apolipoprotein in school age children: comparison with levels of plasma lipids and apolipoproteins].
    Callas N; Poveda E; Baracaldo C; Hernández P; Castillo C; Guerra M
    Biomedica; 2007 Dec; 27(4):526-36. PubMed ID: 18320120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting and preventing acute kidney injury after cardiac surgery.
    Harel Z; Chan CT
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):624-8. PubMed ID: 18941357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E and renal disease.
    Liberopoulos E; Siamopoulos K; Elisaf M
    Am J Kidney Dis; 2004 Feb; 43(2):223-33. PubMed ID: 14750087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute kidney injury after cardiac surgery: focus on modifiable risk factors.
    Karkouti K; Wijeysundera DN; Yau TM; Callum JL; Cheng DC; Crowther M; Dupuis JY; Fremes SE; Kent B; Laflamme C; Lamy A; Legare JF; Mazer CD; McCluskey SA; Rubens FD; Sawchuk C; Beattie WS
    Circulation; 2009 Feb; 119(4):495-502. PubMed ID: 19153273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E gene polymorphism and sodium-lithium countertransport activity.
    Hardman T; Noble MI
    Metabolism; 2001 Nov; 50(11):1386-8. PubMed ID: 11715937
    [No Abstract]   [Full Text] [Related]  

  • 9. Apolipoprotein E polymorphism and dendritic shape in hippocampal interneurons.
    Schönheit B; Glöckner F; Ohm TG
    Neurobiol Aging; 2007 May; 28(5):677-86. PubMed ID: 17023092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apo E gene polymorphism on development of diabetic nephropathy.
    Ilhan N; Kahraman N; Seçkin D; Ilhan N; Colak R
    Cell Biochem Funct; 2007; 25(5):527-32. PubMed ID: 16933203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Asp299Gly Toll-like receptor 4 polymorphism in advanced aortic atherosclerosis.
    Hommels MJ; Kroon AA; Netea MG; de Leeuw PW; Bruggeman CA; Leiner T; Koster DA; Stalenhoef AF; van der Ven AJ
    Neth J Med; 2007 Jun; 65(6):203-7. PubMed ID: 17587646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between Apolipoprotein E polymorphism and nephropathy in type-2 diabetic patients.
    Leiva E; Mujica V; Elematore I; Orrego R; Díaz G; Prieto M; Arredondo M
    Diabetes Res Clin Pract; 2007 Nov; 78(2):196-201. PubMed ID: 17481771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy.
    Hagiwara M; Yamagata K; Matsunaga T; Arakawa Y; Usui J; Shimizu Y; Aita K; Nagata M; Koyama A; Zhang B; Mastunaga A; Saku K; Saito T
    Nephrol Dial Transplant; 2008 Jan; 23(1):381-4. PubMed ID: 17967799
    [No Abstract]   [Full Text] [Related]  

  • 14. Apolipoprotein E and hepatitis C virus.
    Itzhaki RF; Irving WL; Wozniak MA
    Hepatology; 2003 Oct; 38(4):1060. PubMed ID: 14512896
    [No Abstract]   [Full Text] [Related]  

  • 15. Apolipoprotein E and incident hypertension: the Bambuí Health Aging Study.
    Lima-Costa MF; Peixoto SV; Fuzikawa AK; Taufer M; Moriguchi EH
    J Am Geriatr Soc; 2007 Nov; 55(11):1895-7. PubMed ID: 17979915
    [No Abstract]   [Full Text] [Related]  

  • 16. Apolipoprotein E gene polymorphism and myocardial infarction.
    Kolovou GD; Anagnostopoulou KK; Cokkinos DV
    Int J Cardiol; 2009 Apr; 133(2):264-5. PubMed ID: 18190985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E alleles and bicuspid aortic valve stenosis in monozygotic twins.
    Saravanan P; Kadir I
    Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):687-8. PubMed ID: 19304773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid profile and apolipoprotein E polymorphism in essential hypertension.
    Bhavani AB; Sastry KB; Reddy NK; Padma T
    Indian Heart J; 2005; 57(2):151-7. PubMed ID: 16013355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients.
    Kwon MK; Rhee SY; Chon S; Oh S; Woo JT; Kim SW; Kim JW; Kim YS; Jeong KH; Lee SH; Lee TW; Ihm CG
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S228-32. PubMed ID: 17624465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative genomics and neurologic outcome: we can't change who we are.
    Grocott HP
    Can J Anaesth; 2009 Aug; 56(8):562-6. PubMed ID: 19479316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.